Sign Out
Pregnancy: Category D. There is no clinical evidence to support the use of Zoledronic acid in pregnant women. Therefore, Zoledronic acid should not be administered during pregnancy except for life threating hypercalcaemia.
Zoledronic acid should not be used during pregnancy. Zoledronic acid may cause fetal harm when administered to a pregnant woman. Women of childbearing potential should be advised to avoid becoming pregnant during treatment with Zoledronic acid.
Nursing Mothers: It is not known whether Zoledronic acid is excreted into human milk. Because many drugs are excreted in human milk, and Zoledronic acid binds to bone, it should not be administered to a nursing woman.
